Biosensia
in-vitro diagnostics company
Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro...Founded in 2006
Homepage: http://www.biosensia.com/
Total money raised: $4.6M
HQ
Belfield Innovation ParkDublin
IRL
Phone: +353 1 7163650
Updated on Aug 22, 2012
Biosensia at CrunchBase
Diarmuid Flavin CEOBiosensia at CrunchBase
Past
Diarmuid Flavin COO
December, 2011
Biosensia raised $1.6M in unattributed round from ACT Venture Capital, Seroba Bioventures, and Atlantic Bridge
Biosensia Raises €1.2M in Funding 
finsmes.com
February, 2008
Biosensia raised $2.9M in unattributed round from Street Capital, Enterprise Ireland, Seroba Kernel, and Atlantic Bridge
2006
Biosensia was founded in 2006